指南与共识眼底病与葡萄膜炎小儿眼科与斜弱视

国际视网膜学术组织(ARI)、亚太玻璃体视网膜学会(APVRS)与亚太眼科学教授学会(AAPPO)关于Coats病诊断与管理的国际共识与指南

International Consensuses and Guidelines on Diagnosing and Managing Coats Disease by the Academia Retina Internationalis (ARI), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO).
指南 / 共识 · Am J Ophthalmol · 2025-10-17

该共识由国际专家组通过广泛文献检索和讨论,针对Coats病的分类、发病机制、诊断、治疗及预后等52个问题形成48条(92.3%)共识声明,其中75%投票为强烈同意或同意;但在与其他血管病关联、3期和4期治疗、抗VEGF新药获益及人工智能作用等方面仍存争议。

要点

  • 52个问题中48条(92.3%)达成共识,75%投票为强烈同意或同意。
  • 多数专家同意所建议的分类、诊断和预后。
  • 争议集中于与其他血管病关联、3期和4期治疗、抗VEGF新药及人工智能作用。

核心结论

  • 这些辩论反映该病罕见、病理生理复杂且治疗进行性致盲病主要影响儿童的挑战,因此需进一步研究,尤其在未达成共识的领域。

研究设计与样本

  • 通过广泛文献检索覆盖分类模式、疾病、Coats-plus及Coats样反应、病因、可能遗传模式、与其他血管病关系、炎症因子和血管内皮生长因子(VEGF)在发病中的作用、诊断特征、并发症、影像模式、临床发现、鉴别诊断、治疗选择、预后因素和管理新概念。
  • 纳入18位专家对分类、发病机制、诊断和治疗方式、预后争议及疾病管理新概念等问题发表意见。

主要发现

  • 7个部分共52个问题中,专家对48条(92.3%)声明达成共识,其中75%投票为强烈同意或同意。
  • 多数专家同意所建议的分类、诊断和预后。
  • 争议仍存在于与其他血管病关联、3期和4期治疗、抗VEGF新药可能获益及人工智能作用等问题。

关键数值与推荐

  • 7个部分共52个问题,达成共识48条(92.3%),其中75%投票为强烈同意或同意。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需进一步研究,尤其在未达成共识的领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Coats disease is a rare, retinal vascular disorder characterized by telangiectasias, aneurysmal dilations, and progressive exudative retinal detachment. Limited understanding of the disease warranted the need to identify controversial issues through an extensive literature search and a debate and discussion among international panels of experts. METHODS: Extensive literature search was done on multiple aspects of the disease-classification patterns, disease, Coats-plus, and Coats-like response. Other key factors included the etiology, possible genetic patterns, relationship with other vascular disorders, the role of inflammatory factors and vascular endothelial growth factor (VEGF) in the pathogenesis, diagnostic features, and complications. Considering the varying treatment patterns followed, imaging modalities, clinical findings, differential diagnosis, treatment options, prognostic factors, and emerging concepts in management were all covered in the search. Eighteen experts were included to opine on questions spanning classification, pathogenesis, diagnostic and treatment methods, prognostic controversies, and newer concepts in disease management. RESULTS: Of the 52 questions in 7 sections, the experts arrived at a consensus for 48 (92.3%) statements (with 75% voted as strong agreement or agreement). Most experts agreed on the suggested classification, diagnosis, and prognosis. The controversy, however, remained in questions regarding association with other vascular disorders, treatment of stages 3 and 4, possible benefits of newer anti-VEGF agents, and the role of artificial intelligence. CONCLUSIONS: These debates reflect the rarity of the condition, complex pathophysiology, and the challenges of treating a progressive blinding disease primarily affecting children. Hence, further studies are warranted, especially in areas that have not reached a consensus.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mahesh M, Radke NV, Agrawal R, et al. International Consensuses and Guidelines on Diagnosing and Managing Coats Disease by the Academia Retina Internationalis (ARI), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academy of the Asia-Pacific Professors of Ophthalmology (AAPPO). Am J Ophthalmol. 2025. PMID: 41110679. doi:10.1016/j.ajo.2025.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。